Ulixertinib hydrochlorideProduct ingredient for Ulixertinib
- Name
- Ulixertinib hydrochloride
- Drug Entry
- Ulixertinib
Ulixertinib is a a novel, reversible, ATP-competitive ERK1/2 inhibitor with high potency and ERK1/2 selectivity 1. It is currently in clinical trials for the treatment of a wide range of tumors.
- Accession Number
- DBSALT002597
- Structure
Structure for Ulixertinib hydrochloride (DBSALT002597)
- Synonyms
- Ulixertinib HCl